Reckitt Benckiser Group Plc (RB): One of the Best Under-the-Radar Investment Catalysts of the Next Year – Actavis Inc (ACT)

One under-the-radar drug recently lost its patent protection and the result could have huge ramifications for the company that tried to fight the onslaught of a generic competitor...

Keep Reading →